Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 30.5 | 58 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 31.0 | 61 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 30.0 | 73 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 29.0 | 63 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 29.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 40.0 | 49 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 47.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 31.0 | 55 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 36.0 | 41 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 47.0 | 52 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | PDGF-BB | 53.0 | 35 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | PDGF-BB | 25.0 | 55 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | PDGF-BB | 24.0 | 69 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | PDGF-BB | 35.0 | 45 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | PDGF-BB | 28.0 | 49 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | PDGF-BB | 25.5 | 50 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | PDGF-BB | 25.0 | 62 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | PDGF-BB | 26.0 | 61 | ||||
RA2159 | 2 | PDGF-BB | 25.0 | 62 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | PDGF-BB | 30.5 | 68 | ||||
N2645 | 2 | PDGF-BB | 28.0 | 37 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | PDGF-BB | 28.0 | 47 | ||||
RA2708 | 2 | PDGF-BB | 35.0 | 47 | |||||||
0 | PDGF-BB | 28.0 | 49 | ||||||||
0 | PDGF-BB | 23.0 | 34 |